Effects of a methanolic fraction of soybean seeds on the transcriptional activity of peroxisome proliferator-activated receptors (PPAR)

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 6, 2009, Pages 545-550

  Carrara, V S ^a   Amato, A A ^b   Neves, F A R ^b   Bazotte, R B ^a   Mandarino, J M G ^c   Nakamura, C V ^a   Filho, B P D ^a   Cortez, D A G ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c EMBRAPA CERRADOS   (Brazil)

Author keywords

Isoflavones; Nuclear receptors; PPAR ; PPAR ; PPAR ; Soybean

Indexed keywords

BEZAFIBRATE; DAIDZEIN; DAIDZIN; GENISTEIN; GENISTIN; GLYCITEIN; GLYCITIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE; MALONYLDAIDZIN; MALONYLGENISTIN; MALONYLGLYCITIN; METHANOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MECHANISM; FRACTIONATION; GENE ACTIVATION; GENETIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PLANT SEED; SEED HUSK; SOYBEAN; TRANSCRIPTION INITIATION; TRANSGENIC PLANT;

GLYCINE MAX;

EID: 68149181863     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000600011     Document Type: Article

References (22)

1. Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 2005; 16: 321-330.
2. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-282.
3. Obst JM, Seamark RF. Hormone studies on ewes grazing an oestrogenic (Yarloop clover) pasture during the reproductive cycle. Aust J Biol Sci 1975; 28: 279-290.
4. Wanda GJ, Starcke S, Zierau O, Njamen D, Richter T, Vollmer G. Estrogenic activity of griffonianone C, an isoflavone from the root bark of Millettia griffoniana: regulation of the expression of estrogen responsive genes in uterus and liver of ovariectomized rats. Planta Med 2007; 73: 512-518.
5. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 2001; 81: 1269-1304.
6. Kilgore KS, Billin AN. PPARbeta/delta ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 2008; 9: 463-469.
7. Mandard S, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 2004; 61: 393-416.
8. Davis J, Higginbotham A, O'Connor T, Moustaid-Moussa N, Tebbe A, Kim YC, et al. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann Nutr Metab 2007; 51: 42-52.
9. Shearer BG, Steger DJ, Way JM, Stanley TB, Lobe DC, Grillot DA, et al. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol 2008; 22: 523-529.
10. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003; 133: 1238-1243.
11. Mezei O, Li Y, Mullen E, Ross-Viola JS, Shay NF. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms. Physiol Genomics 2006; 26: 8-14.
12. Chacko BK, Chandler RT, D'Alessandro TL, Mundhekar A, Khoo NK, Botting N, et al. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J Nutr 2007; 137: 351-356.
13. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995; 83: 803-812.
14. Berhow MA. Modern analytical techniques for flavonoid determination. Adv Exp Med Biol 2002; 505: 61-76.
15. Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, et al. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 2003; 92: 518-524.
16. Sheng L, Ye P, Liu YX, Han CG, Zhang ZY. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro. Clin Exp Hypertens 2008; 30: 109-119.
17. Rees WD, McNeil CJ, Maloney CA. The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res 2008; 2008: 459030.
18. Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, et al. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 2008; 243: 236-243.
19. Shan W, Nicol CJ, Ito S, Bility MT, Kennett MJ, Ward JM, et al. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. Hepatology 2008; 47: 225-235.
20. Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, Chang S, et al. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2008; 128: 370-377.
21. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes 2007; 31: 1302-1310.
22. Kim S, Shin HJ, Kim SY, Kim JH, Lee YS, Kim DH, et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol 2004; 220: 51-58.